How an Unproven Alzheimer’s Drug Got Approved by BY PAM BELLUCK, SHEILA KAPLAN AND REBECCA ROBBINS

This entry was posted in Health Weight Watchers and tagged Health NYT on by

Though some of its own senior officials said there was little evidence of benefit for patients, the F.D.A. nonetheless greenlighted Biogen’s Aduhelm, or aducanumab.

Published: July 20, 2021 at 04:12AM

from NYT Health https://ift.tt/2V2fsC8